ScreenerHero
ELEssilorLuxottica Société anonyme
EPA · FR · Healthcare · Medical Instruments & Supplies · essilorluxottica.com
163.20EUR+0.55%Mkt Cap: 81.53B $P/E: 30.50

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1
STVN
Stevanato Group S.p.A.
$6.10BUSDP/E 39.2

Key Statistics

Company
Market Cap81.53B $
Enterprise Value95.85B $
Revenue (TTM)31.83B $
Gross Profit18.75B $
Net Income (TTM)2.52B $
Revenue/Share68.97 USD
Last Price163.20 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees213.9K
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINFR0000121667
Valuation
P/E (Trailing)30.50
P/E (Forward)19.86
PEG1.71
EV/EBITDA15.07
EV/Revenue3.01
P/S2.53
P/B1.89
EPS (TTM)5.34
EPS (Forward)8.12
52W Range
159.202% of range323.80
52W High323.80 EUR
52W Low159.20 EUR
Profitability
Gross Margin60.56%
Oper. Margin15.37%
EBITDA Margin19.99%
Profit Margin8.13%
ROE5.95%
ROA3.62%
Growth
Revenue Growth5.70%
Earnings Growth12.30%
Cash Flow & Leverage
Operating CF5.75B $
CapEx (TTM)1.66B $
FCF Margin11.22%
FCF Yield4.38%
Net Debt14.55B $
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity0.37
Current Ratio0.89
Quick Ratio0.50
Book Value/Sh85.33 EUR
Cash/Share4.202 EUR
Dividends
Fwd Div Rate4.000 EUR
Trail. Div Rate4.000 EUR
Div. Yield2.45%
5Y Avg Yield1.62%
Payout Ratio74.77%
Ex-Div DateMay 5, 2026
Pay Date—
Splits
Last Split1.02193:1
Split DateMay 6, 2024
Analyst Consensus
Rating—
Target (Mean)243.30 EUR
Upside (mean)+49.1%
Target Range174.00 EUR – 361.00 EUR
€174.00+49.1% to mean€361.00
# Analysts23
Ownership
Shares Out.459.59M
Float292.07M
Insiders36.99%
Institutions28.03%
Technical
SMA 50169.39 (-3.7%)
SMA 200217.97 (-25.1%)
Beta0.55
S&P 52W Chg18.16%
Avg Vol (30d)378.10K
Avg Vol (10d)626.70K
Technical Indicators
RSI (14)42.2
MACD-1.7340
MACD Signal-1.1920
MACD Hist.-0.5420
BB Upper175.22 EUR
BB Middle166.71 EUR
BB Lower158.19 EUR
BB Width10.21%
ATR (14)4.826 EUR
Vol Ratio (20d)0.35x